Spatial Heterogeneity in Sarcoma 18F-FDG Uptake as a Predictor of Patient Outcome
Top Cited Papers
Open Access
- 7 November 2008
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 49 (12) , 1973-1979
- https://doi.org/10.2967/jnumed.108.053397
Abstract
18F-FDG PET images of tumors often display highly heterogeneous spatial distribution of 18F-FDG–positive pixels. We proposed that this heterogeneity in 18F-FDG spatial distribution can be used to predict tumor biologic aggressiveness. This study presents data to support the hypothesis that a new heterogeneity-analysis algorithm applied to 18F-FDG PET images of tumors in patients is predictive of patient outcome. Methods: 18F-FDG PET images from 238 patients with sarcoma were analyzed using a new algorithm for heterogeneity analysis in tumor 18F-FDG spatial distribution. Patient characteristics, tumor histology, and patient outcome were compared with image analysis results using univariate and multivariate analysis. Cox proportional hazards models were used to further analyze the significance of the data associations. Results: Statistical analyses show that heterogeneity analysis is a strong independent predictor of patient outcome. Conclusion: The new 18F-FDG PET tumor image heterogeneity analysis method is validated for the ability to predict patient outcome in a clinical population of patients with sarcoma. This method can be extended to other PET image datasets in which heterogeneity in tissue uptake of a radiotracer may predict patient outcome.Keywords
This publication has 17 references indexed in Scilit:
- A Cascade of Modules of a Network Defines Cancer ProgressionCancer Research, 2006
- Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.2006
- Multiple mutations and cancerProceedings of the National Academy of Sciences, 2003
- Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Clinical Value of [18-F] Fluorodeoxyglucose Positron Emission Tomography Imaging in Soft Tissue SarcomasAnnals of Surgery, 2000
- The Hallmarks of CancerCell, 2000
- Genetic instability and darwinian selection in tumoursTrends in Cell Biology, 1999
- Positron Emission Tomography in Grading Soft Tissue SarcomasSeminars in Musculoskeletal Radiology, 1999
- Tumor metabolic rates in sarcoma using FDG PET.1998
- Regional Differences in the Growth of Normal and Neoplastic CellsScience, 1982